Thymidine Phosphorylase Deficiency or Inhibition Preserves Cardiac Function in Mice With Acute Myocardial Infarction

BACKGROUND: Ischemic cardiovascular disease is the leading cause of death worldwide. Current pharmacologic therapy has multiple limitations, and patients remain symptomatic despite maximal medical therapies. Deficiency or inhibition of thymidine phosphorylase (TYMP) in mice reduces thrombosis, sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lili, Yue, Hong, Rorabaugh, Boyd R., Li, Oliver Q. Y., DeHart, Autumn R., Toloza‐Alvarez, Gretel, Hong, Liang, Denvir, James, Thompson, Ellen, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122909/
https://www.ncbi.nlm.nih.gov/pubmed/36974758
http://dx.doi.org/10.1161/JAHA.122.028023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122909/
https://www.ncbi.nlm.nih.gov/pubmed/36974758
http://dx.doi.org/10.1161/JAHA.122.028023

Ejemplares similares